Fresenius Medical Care AG (FMCQF) Capital Expenditures (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has reported Capital Expenditures for 17 consecutive years, with -$486.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Capital Expenditures fell 95.42% year-over-year to -$486.6 million; the TTM figure through Dec 2025 stood at -$1.2 billion (down 17.53% YoY), while the FY2025 annual figure was -$1.0 billion, down 42.96% from the prior year.
• Capital Expenditures came in at -$486.6 million for Q4 2025 at Fresenius Medical Care AG, down from -$249.0 million in the prior quarter.
• The five-year high for Capital Expenditures was -$206.1 million in Q4 2022, with the low at -$486.6 million in Q4 2025.
• Average Capital Expenditures over 5 years is -$301.3 million, with a median of -$257.1 million recorded in 2023.
• Across the five-year window, Capital Expenditures surged 33.03% in 2022 and plunged 95.42% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$307.7 million in 2021, then soared by 33.03% to -$206.1 million in 2022, then slipped by 24.78% to -$257.1 million in 2023, then increased by 3.18% to -$249.0 million in 2024, then plunged by 95.42% to -$486.6 million in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered -$486.6 million, -$249.0 million, and -$257.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.